Literature DB >> 12115832

Measuring the surface area of aluminum hydroxide adjuvant.

Cliff T Johnston1, Shan-Li Wang, Stanley L Hem.   

Abstract

The traditional method of determining surface area, nitrogen gas sorption, requires complete drying of the sample prior to analysis. This technique is not suitable for aluminum hydroxide adjuvant because it is composed of submicron, fibrous particles that agglomerate irreversibly upon complete removal of water. In this study, the surface area of a commercial aluminum hydroxide adjuvant was determined by a gravimetric/FTIR method that measures the water adsorption capacity. This technique does not require complete drying of the adjuvant. Five replicate determinations gave a mean surface area of 514 m(2)/g and a 95% confidence interval of 36 m(2)/g for a commercial aluminum hydroxide adjuvant. The X-ray diffraction pattern and the Scherrer equation were used to calculate the dimensions of the primary crystallites. The average calculated dimensions were 4.5 x 2.2 x 10 nm. Based on these dimensions, the mean calculated surface area of the commercial aluminum hydroxide adjuvant was 509 m(2)/g, and the 95% confidential interval was 30 m(2)/g. The close agreement between the two surface area values indicates that either method may be used to determine the surface area of aluminum hydroxide adjuvant. The high surface area, which was determined by two methods, is an important property of aluminum hydroxide adjuvants, and is the basis for the intrinsically high protein adsorption capacity. Copyright 2002 Wiley-Liss Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115832     DOI: 10.1002/jps.10166

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Measuring surface roughness of pharmaceutical powders using vapor sorption methods.

Authors:  Daniel J Burnett; Jerry Y Y Heng; Frank Thielmann; Armando R Garcia; Majid Naderi; Manaswini Acharya
Journal:  AAPS PharmSciTech       Date:  2010-12-18       Impact factor: 3.246

2.  Anthrax sub-unit vaccine: the structural consequences of binding rPA83 to Alhydrogel®.

Authors:  Andrei Soliakov; Ian F Kelly; Jeremy H Lakey; Allan Watkinson
Journal:  Eur J Pharm Biopharm       Date:  2011-09-22       Impact factor: 5.571

Review 3.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior.

Authors:  Ge Yu; Zhihui Liang; Zilan Yu; Min Li; Wenqi Yang; Yawei Zhang; Yuhang Zhao; Cheng Yang; Changying Xue; Li Shi; Bingbing Sun
Journal:  NPJ Vaccines       Date:  2022-06-23       Impact factor: 9.399

5.  Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.

Authors:  Kimberly J Hassett; Megan C Cousins; Lilia A Rabia; Chrystal M Chadwick; Joanne M O'Hara; Pradyot Nandi; Robert N Brey; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2013-04-10       Impact factor: 5.571

6.  Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA).

Authors:  Daming Zhu; Shuhui Huang; Elizabeth Gebregeorgis; Holly McClellan; Weili Dai; Louis Miller; Allan Saul
Journal:  J Immunol Methods       Date:  2009-03-27       Impact factor: 2.303

7.  Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.

Authors:  Amber L Clausi; Andrea Morin; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

8.  Gamma irradiation of active self-healing PLGA microspheres for efficient aqueous encapsulation of vaccine antigens.

Authors:  Kashappa-Goud H Desai; Samer Kadous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2013-03-21       Impact factor: 4.200

9.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

Review 10.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.